Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma

Cancer Science

Volumn 102, Issue 1, 2011, Pages 150-156

  Hamada, Shin ^a   Satoh, Kennichi ^a   Hirota, Morihisa ^a   Kanno, Atsushi ^a   Ishida, Kazuyuki ^a   Umino, Jun ^a   Ito, Hiromichi ^a   Kikuta, Kazuhiro ^a   Kume, Kiyoshi ^a   Masamune, Atsushi ^a   Katayose, Yu ^a   Unno, Michiaki ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN S 100;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT CARCINOMA; BILE DUCT DILATATION; BILE DUCT OBSTRUCTION; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC ACCURACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CALCIUM-BINDING PROTEINS; CHOLANGIOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 78650195076     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01757.x     Document Type: Article

References (25)

1. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-25.
2. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2: 10.
3. Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 2006; 45: 856-67.
4. Kitajima Y, Ohara H, Nakazawa T et al. Usefulness of transpapillary bile duct brushing cytology and forceps biopsy for improved diagnosis in patients with biliary strictures. J Gastroenterol Hepatol 2007; 22: 1615-20.
5. Dumonceau JM, Casco C, Landoni N et al. A new method of biliary sampling for cytopathological examination during endoscopic retrograde cholangio-graphy. Am J Gastroenterol 2007; 102: 550-7.
6. Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15: 4240-62.
7. Boberg KM, Schrumpf E. Diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep 2004; 6: 52-9.
8. Fritscher-Ravens A, Broering DC, Knoefel WT et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol 2004; 99: 45-51.
9. DeWitt J, Misra VL, Leblanc JK, McHenry L, Sherman S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc 2006; 64: 325-33.
10. Lee JH, Salem R, Aslanian H, Chacho M, Topazian M. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol 2004; 99: 1069-73.
11. Obama K, Ura K, Li M et al. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology 2005; 41: 1339-48.
12. Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 1995; 25: 638-43.
13. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 2004; 279: 5059-65.
14. Ohuchida K, Mizumoto K, Egami T et al. S100P is an early developmental marker of pancreatic carcinogenesis. Clin Cancer Res 2006; 12: 5411-6.
15. Arumugam T, Simeone DM, Van Golen K, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 2005; 11: 5356-64.
16. Hamada S, Satoh K, Hirota M et al. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J Cell Physiol 2007; 213: 768-74.
17. Hamada S, Watanabe K, Hirota M et al. beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1. Biochem Biophys Res Commun 2007; 355: 240-4.
18. Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 1999; 31: 712-7.
19. Levy M, Lin F, Xu H, Dhall D, Spaulding BO, Wang HL. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Hum Pathol 2010; 41(9): 1210-19.
20. Jahng AW, Chung D, Pham B et al. Staining for intracytoplasmic lumina and CAM5.2 increases the detection rate for bile duct cancers. Endoscopy 2009; 41: 965-70.
21. Itoi T, Shinohara Y, Takeda K et al. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers. Int J Mol Med 2001; 7: 281-7.
22. Feldmann G, Nattermann J, Nischalke HD et al. Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer. Endoscopy 2006; 38: 604-9.
23. Tsukada K, Takada T, Miyazaki M et al. Diagnosis of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008; 15: 31-40.
24. Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol 2009; 6: 533-41.
25. Tamada K, Kanai N, Wada S et al. Utility and limitations of intraductal ultrasonography in distinguishing longitudinal cancer extension along the bile duct from inflammatory wall thickening. Abdom Imaging 2001; 26: 623-31.